$49.29 3.6%
AMPH Stock Price vs. AI Score
Data gathered: October 14

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Amphastar P

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.


Amphastar P
Price $49.29
Target Price Sign up
Volume 283,010
Market Cap $2.33B
Year Range $36.99 - $56.02
Dividend Yield 0%
PE Ratio 15.1
Analyst Rating 60% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24182M87M95M38M52M0.940
Q1 '24172M82M90M43M62M1.040
Q4 '23178M82M96M36M57M0.880
Q3 '23181M72M108M49M83M1.150
Q2 '23146M73M73M26M36M0.650

Insider Transactions View All

Zhou Rong filed to sell 118,388 shares at $48.3.
September 17 '24
Petersen Floyd F. filed to sell 75,409 shares at $46.5.
September 6 '24
Zhou Rong filed to sell 118,388 shares at $48.4.
August 27 '24
PRINS RICHARD K filed to sell 33,971 shares at $43.1.
August 13 '24
PETERS WILLIAM J filed to sell 94,103 shares at $44.2.
August 2 '24

What is the Market Cap of Amphastar P?

The Market Cap of Amphastar P is $2.33B.

What is Amphastar P's PE Ratio?

As of today, Amphastar P's PE (Price to Earnings) ratio is 15.1.

What is the current stock price of Amphastar P?

Currently, the price of one share of Amphastar P stock is $49.29.

How can I analyze the AMPH stock price chart for investment decisions?

The AMPH stock price chart above provides a comprehensive visual representation of Amphastar P's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amphastar P shares. Our platform offers an up-to-date AMPH stock price chart, along with technical data analysis and alternative data insights.

Does AMPH offer dividends to its shareholders?

As of our latest update, Amphastar P (AMPH) does not offer dividends to its shareholders. Investors interested in Amphastar P should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Amphastar P?

Some of the similar stocks of Amphastar P are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.